Mutagenicity of the major adduct formed by reaction of malondialdehyde with DNA

S. P. Fink , L. I. Mamett , G. R. Reddy
The FASEB Journal 11 ( 9)

1997
MUTAGENICITY IN ESCHERICHIA COLI OF THE MAJOR DNA ADDUCT DERIVED FROM THE ENDOGENOUS MUTAGEN MALONDIALDEHYDE

S. P. Fink , G. R. Reddy , L. J. Marnett
Proceedings of the National Academy of Sciences of the United States of America 94 ( 16) 8652 -8657

127
1997
Refractory ceramic fibers activate alveolar macrophage eicosanoid and cytokine release

G. D. Leikauf , S. P. Fink , M. L. Miller , J. E. Lockey
Journal of Applied Physiology 78 ( 1) 164 -171

23
1995
Inhibition of the prostaglandin-degrading enzyme 15-PGDH potentiates tissue regeneration

Yongyou Zhang , Amar Desai , Sung Yeun Yang , Ki Beom Bae
Science 348 ( 6240) 2340

152
2015
Aspirin and the Risk of Colorectal Cancer in Relation to the Expression of 15-Hydroxyprostaglandin Dehydrogenase (HPGD)

S. P. Fink , M. Yamauchi , R. Nishihara , S. Jung
Science Translational Medicine 6 ( 233)

79
2014
15-Hydroxyprostaglandin dehydrogenase inactivation as a mechanism of resistance to celecoxib chemoprevention of colon tumors

M. Yan , S.-J. Myung , S. P. Fink , E. Lawrence
Proceedings of the National Academy of Sciences of the United States of America 106 ( 23) 9409 -9413

90
2009
Taxol-induced flexibility of microtubules and its reversal by MAP-2 and Tau.

R.B. Dye , S.P. Fink , R.C. Williams
Journal of Biological Chemistry 268 ( 10) 6847 -6850

121
1993
Endogenous DNA adducts

LJ Marnett , C Rouzer , SP Fink , L Neidernhofer
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 212 72 -TOXI

1996
Transforming Growth Factor-β-induced Growth Inhibition in a Smad4 Mutant Colon Adenoma Cell Line

Sandra E. Swinler , Bert Vogelstein , Joan Massagué , Kenneth W. Kinzler
Cancer Research 61 ( 1) 256 -260

67
2001
Inhibition of 15-hydroxyprostaglandin dehydrogenase by Helicobacter pylori in human gastric carcinogenesis.

Yeon-Mi Ryu , Seung-Jae Myung , Young Soo Park , Dong-Hoon Yang
Cancer Prevention Research 6 ( 4) 349 -359

10
2013
Inactivating Mutation in the Prostaglandin Transporter Gene, SLCO2A1, Associated with Familial Digital Clubbing, Colon Neoplasia, and NSAID Resistance

Kishore Guda , Stephen P. Fink , Ginger L. Milne , Neil Molyneaux
Cancer Prevention Research 7 ( 8) 805 -812

22
2014
Genetic variation in 15-hydroxyprostaglandin dehydrogenase and colon cancer susceptibility.

Cheryl L. Thompson , Stephen P. Fink , James D. Lutterbaugh , Robert C. Elston
PLOS ONE 8 ( 5)

14
2013
Repair of Propanodeoxyguanosine by Nucleotide Excision Repairin Vivoandin Vitro

Kristin A. Johnson , Stephen P. Fink , Lawrence J. Marnett
Journal of Biological Chemistry 272 ( 17) 11434 -11438

81
1997
Induction of KIAA1199/CEMIP is associated with colon cancer phenotype and poor patient survival

Stephen P. Fink , Lois L. Myeroff , Revital Kariv , Petra Platzer
Oncotarget 6 ( 31) 30500 -30515

66
2015
MutS recognition of exocyclic DNA adducts that are endogenous products of lipid oxidation.

Kristin A. Johnson , Michelle L. Mierzwa , Stephen P. Fink , Lawrence J. Marnett
Journal of Biological Chemistry 274 ( 38) 27112 -27118

34
1999
Ugene, a Newly Identified Protein That Is Commonly Overexpressed in Cancer and Binds Uracil DNA Glycosylase

Chunguang Guo , Xiaodong Zhang , Stephen P. Fink , Petra Platzer
Cancer Research 68 ( 15) 6118 -6126

16
2008
Application of Next-Generation Sequencing in RNA Biomarker Discovery in Cancer Research

Stephen P. Fink , Kishore Guda
Next Generation Sequencing in Cancer Research 183 -197

1
2013